Compare COMBAT DRUGS with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs DENIS CHEM LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS DENIS CHEM LAB DECIPHER LABS/
DENIS CHEM LAB
 
P/E (TTM) x 24.1 16.9 142.5% View Chart
P/BV x 5.4 1.6 339.8% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 DECIPHER LABS   DENIS CHEM LAB
EQUITY SHARE DATA
    DECIPHER LABS
Mar-21
DENIS CHEM LAB
Mar-21
DECIPHER LABS/
DENIS CHEM LAB
5-Yr Chart
Click to enlarge
High Rs4159 69.3%   
Low Rs1827 66.5%   
Sales per share (Unadj.) Rs55.078.8 69.8%  
Earnings per share (Unadj.) Rs1.41.6 85.2%  
Cash flow per share (Unadj.) Rs2.25.9 37.1%  
Dividends per share (Unadj.) Rs00.75 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs13.644.3 30.6%  
Shares outstanding (eoy) m10.1013.88 72.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.50.5 98.0%   
Avg P/E ratio x21.326.5 80.4%  
P/CF ratio (eoy) x13.47.3 184.4%  
Price / Book Value ratio x2.21.0 223.8%  
Dividend payout %046.0 0.0%   
Avg Mkt Cap Rs m298599 49.8%   
No. of employees `000NANA-   
Total wages/salary Rs m473106 447.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m5561,093 50.8%  
Other income Rs m63 186.7%   
Total revenues Rs m5621,097 51.3%   
Gross profit Rs m35103 34.0%  
Depreciation Rs m860 13.7%   
Interest Rs m1216 75.3%   
Profit before tax Rs m2131 69.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m78 89.9%   
Profit after tax Rs m1423 62.0%  
Gross profit margin %6.39.4 66.9%  
Effective tax rate %34.526.7 129.6%   
Net profit margin %2.52.1 121.9%  
BALANCE SHEET DATA
Current assets Rs m225486 46.4%   
Current liabilities Rs m173241 71.7%   
Net working cap to sales %9.422.3 42.2%  
Current ratio x1.32.0 64.7%  
Inventory Days Days777 1,026.2%  
Debtors Days Days766109,770,527 0.0%  
Net fixed assets Rs m161437 36.9%   
Share capital Rs m101139 72.8%   
"Free" reserves Rs m36476 7.5%   
Net worth Rs m137615 22.3%   
Long term debt Rs m6745 150.5%   
Total assets Rs m387923 41.9%  
Interest coverage x2.83.0 94.8%   
Debt to equity ratio x0.50.1 676.4%  
Sales to assets ratio x1.41.2 121.3%   
Return on assets %6.74.1 160.8%  
Return on equity %10.23.7 278.3%  
Return on capital %16.27.0 230.8%  
Exports to sales %04.6 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA50 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m050 0.0%   
Fx outflow Rs m00-   
Net fx Rs m050 0.0%   
CASH FLOW
From Operations Rs m1880 23.0%  
From Investments Rs m-3-11 27.8%  
From Financial Activity Rs m40-55 -72.4%  
Net Cashflow Rs m5513 413.7%  

Share Holding

Indian Promoters % 0.0 39.0 -  
Foreign collaborators % 39.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 61.0 61.0 100.0%  
Shareholders   39,275 3,059 1,283.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DECIPHER LABS SHARE PRICE


Jan 25, 2022 03:37 PM

TRACK DECIPHER LABS

  • Track your investment in DECIPHER LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DECIPHER LABS 5-YR ANALYSIS

COMPARE DECIPHER LABS WITH

MARKET STATS